Data Analysis
Generics companies can lose a competitive advantage by invalidating patents at the board, but it’s still a good option in many circumstances
Ganesh Venkatraman of MaxVal and Meissner Bolte’s Florian Henke and Florian Meyer dive into the numbers on UPC opt-outs by technology area and country, and more
A sharp drop in utility model grants indicates that the CNIPA is focusing more on quality over quantity, but issues over bad-faith filings refuse to go away
Sources say China’s lead on generative AI patent filing could have been driven by lax laws, incentives, and spurious applications
Sponsored
